Filing Flows › Prelude Therapeutics (PRLD) › Who owns the stock
Who owns Prelude Therapeutics (PRLD) stock
71 funds reported Prelude Therapeutics (PRLD) shares in their latest 13F filings, worth $268M in all. The largest holder is Orbimed Advisors LLC ($73.2M). Last quarter 46 funds added to their stakes and 26 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Orbimed Advisors LLC | 13,724,571 | $73.2M | increase | 2026-06-30 |
| Baker Bros. Advisors LP | 10,123,824 | $54.0M | unchanged | 2026-06-30 |
| RA Capital Management, L.P. | 6,475,882 | $34.5M | new | 2026-06-30 |
| Soleus Capital Management, L.P. | 3,378,378 | $18.0M | new | 2026-06-30 |
| Kynam Capital Management, LP | 2,415,087 | $12.9M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 2,009,445 | $10.7M | increase | 2026-06-30 |
| BlackRock | 1,797,501 | $9.6M | increase | 2026-06-30 |
| Sphera Funds Management | 1,019,832 | $5.4M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 993,369 | $5.3M | increase | 2026-06-30 |
| ADAR1 Capital Management, LLC | 900,900 | $4.8M | increase | 2026-06-30 |
| Millennium Management LLC | 844,993 | $4.5M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 841,862 | $4.5M | increase | 2026-06-30 |
| Vanguard Group | 1,413,986 | $4.1M | increase | 2025-12-31 |
| Adage Capital Partners GP, L.L.C. | 766,095 | $4.1M | new | 2026-06-30 |
| Acadian Asset Management LLC | 611,359 | $3.3M | increase | 2026-06-30 |
Prelude Therapeutics' latest quarter
Prelude Therapeutics, Q2 2026: revenue $5.7M, operating margin -270.9%, net loss $13.9M, operating cash flow −$15.6M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most PRLD stock?
By the latest 13F filings: Orbimed Advisors LLC ($73.2M); Baker Bros. Advisors LP ($54.0M); RA Capital Management, L.P. ($34.5M); Soleus Capital Management, L.P. ($18.0M); Kynam Capital Management, LP ($12.9M).
What is the short interest in PRLD?
5,097,463 shares were sold short at the 2026-10-15 settlement, 11.42% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.